These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 17386844)

  • 1. The failing cardiomyocyte.
    Harding SE
    Heart Fail Clin; 2005 Jul; 1(2):171-81. PubMed ID: 17386844
    [No Abstract]   [Full Text] [Related]  

  • 2. Beta-adrenergic receptor desensitization in cardiac hypertrophy and heart failure.
    Choi DJ; Rockman HA
    Cell Biochem Biophys; 1999; 31(3):321-9. PubMed ID: 10736754
    [No Abstract]   [Full Text] [Related]  

  • 3. Myocardial disease in failing hearts: defective excitation-contraction coupling.
    Wehrens XH; Marks AR
    Cold Spring Harb Symp Quant Biol; 2002; 67():533-41. PubMed ID: 12858580
    [No Abstract]   [Full Text] [Related]  

  • 4. How do beta-blockers improve ventricular function in patients with congestive heart failure?
    Barry WH; Gilbert EM
    Circulation; 2003 May; 107(19):2395-7. PubMed ID: 12756189
    [No Abstract]   [Full Text] [Related]  

  • 5. Chronic partial unloading restores beta-adrenergic responsiveness and reverses receptor downregulation in failing rat hearts.
    Wang J; Tsukashita M; Nishina T; Marui A; Yoshikawa E; Muranaka H; Matsuoka S; Ikeda T
    J Thorac Cardiovasc Surg; 2009 Feb; 137(2):465-70. PubMed ID: 19185171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defects in cardiomyocyte function: role of beta-adrenergic receptor dysfunction.
    Perrino C; Esposito G; Rockman HA
    Panminerva Med; 2005 Sep; 47(3):143-55. PubMed ID: 16462723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Beta-adrenergic receptors in normal and failing heart].
    Mackiewicz U; Klemenska E; Beresewicz A
    Kardiol Pol; 2007 Mar; 65(3):294-302. PubMed ID: 17436160
    [No Abstract]   [Full Text] [Related]  

  • 8. Beta 2 adrenoceptor agonists. Pharmacology, metabolic effects and arrhythmias.
    Canepa-Anson R; Dawson JR; Frankl WS; Kuan P; Sutton GC; Reuben S; Poole-Wilson PA
    Eur Heart J; 1982 Dec; 3 Suppl D():129-34. PubMed ID: 6130946
    [No Abstract]   [Full Text] [Related]  

  • 9. T-tubule trouble.
    Orchard C
    J Physiol; 2006 Jul; 574(Pt 2):330. PubMed ID: 16728445
    [No Abstract]   [Full Text] [Related]  

  • 10. Structural components of cardiomyocyte remodeling: summation.
    Zile MR
    J Card Fail; 2002 Dec; 8(6 Suppl):S311-3. PubMed ID: 12555137
    [No Abstract]   [Full Text] [Related]  

  • 11. [New aspects of the pathogenesis of heart failure].
    Erdmann E; Böhm M; Schwinger RH; Beuckelmann DJ
    Internist (Berl); 1990 Oct; 31(10):632-40. PubMed ID: 2178156
    [No Abstract]   [Full Text] [Related]  

  • 12. Diastolic release of calcium from the sarcoplasmic reticulum: a potential target for treating triggered arrhythmias and heart failure.
    Shannon TR; Lew WY
    J Am Coll Cardiol; 2009 May; 53(21):2006-8. PubMed ID: 19460615
    [No Abstract]   [Full Text] [Related]  

  • 13. Human stem cells for heart failure treatment ready for prime time?
    Condorelli G; Catalucci D
    J Am Coll Cardiol; 2007 Nov; 50(19):1894-5. PubMed ID: 17980257
    [No Abstract]   [Full Text] [Related]  

  • 14. Multiple defects in intracellular calcium cycling in whole failing rat heart.
    Wasserstrom JA; Sharma R; Kapur S; Kelly JE; Kadish AH; Balke CW; Aistrup GL
    Circ Heart Fail; 2009 May; 2(3):223-32. PubMed ID: 19808344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What are the consequences of phosphorylation and hyperphosphorylation of ryanodine receptors in normal and failing heart?
    Bridge JH; Savio-Galimberti E
    Circ Res; 2008 May; 102(9):995-7. PubMed ID: 18467636
    [No Abstract]   [Full Text] [Related]  

  • 16. Adrenergic control of the force-frequency relation.
    Ross J; Miura T; Kambayashi M; Eising GP; Ryu KH
    Circulation; 1995 Oct; 92(8):2327-32. PubMed ID: 7554218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Molecular mechanisms of cardiomyogenesis and perspectives of cardiomyocyte regeneration in cardiac failure].
    Shirinskiĭ VP; Khapchaev AIu; Stepanova OV
    Mol Biol (Mosk); 2008; 42(5):856-66. PubMed ID: 18988534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The third beta is not the charm.
    Bond RA; Lefkowitz RJ
    J Clin Invest; 1996 Jul; 98(2):241. PubMed ID: 8755628
    [No Abstract]   [Full Text] [Related]  

  • 19. Increased cardiomyocyte function and Ca2+ transients in mice during early congestive heart failure.
    Mørk HK; Sjaastad I; Sande JB; Periasamy M; Sejersted OM; Louch WE
    J Mol Cell Cardiol; 2007 Aug; 43(2):177-86. PubMed ID: 17574269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Compartmentalization of cardiac beta-adrenergic inotropy modulation by phosphodiesterase type 5.
    Takimoto E; Belardi D; Tocchetti CG; Vahebi S; Cormaci G; Ketner EA; Moens AL; Champion HC; Kass DA
    Circulation; 2007 Apr; 115(16):2159-67. PubMed ID: 17420342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.